Niagen Bioscience
Jasmine Sadler currently serves as a Creative Project Manager at ChromaDex, a bioscience company focused on healthy aging and the creator of the NAD+ precursor nicotinamide riboside (NR), marketed as Niagen®. Prior to this role, Jasmine held positions at Primary.Health as a Client Success Project Manager and Client Success Project Coordinator, where responsibilities included managing client-facing projects and developing training resources. Jasmine's career began at Balanced Body as a Marketing Project Coordinator and Marketing Intern, contributing to various marketing initiatives. Additionally, experience as a Social Media and Special Programs Assistant at the Cesar Chavez Community Action Center involved managing social media accounts and creating promotional content. Jasmine holds a Bachelor of Science in Marketing from San José State University and an Associate of Arts and Sciences in Business Administration from Sacramento City College.
This person is not in any offices
Niagen Bioscience
Niagen Bioscience (NASDAQ:NAGE), founded in 1999 and formerly known as ChromaDex, is the global authority on nicotinamide adenine dinucleotide (NAD+), dedicated to advancing healthy-aging science. Our world-renowned scientists collaborate with independent investigators from leading universities and research institutions worldwide to explore the full potential of NAD+, a vital coenzyme found in every cell that declines with age and everyday stressors. Setting the benchmark as the gold standard in scientific rigor, safety, quality, and transparency, Niagen Bioscience is the innovator behind Niagen® (patented nicotinamide riboside, or NR), the most efficient and superior-quality NAD+ booster available. Our ingredient is backed by 35+ human clinical trials and 400+ peer-reviewed studies, making it one of the world's most extensively researched and validated NAD+ precursors. We offer two distinct product lines: Tru Niagen®, the number one healthy-aging NAD+ supplement in the United States*, clinically proven to increase NAD+ levels and help people transform the way they age (available at www.truniagen.com) Niagen® Plus, our premium pharmaceutical-grade NAD+ therapy featuring Niagen™ IV and injectables, available exclusively at clinics with a prescription (www.niagenplus.com) Our robust patent portfolio protects NR and other NAD+ precursors. As pioneers in NAD+ technology, we continue to demonstrate our commitment to excellence, innovation, and integrity through our two California locations (Tustin and Westwood) and our premier research Laboratory & Innovation Center in Longmont, CO. Visit www.niagenbioscience.com for press releases, news, and financial information. Interested in joining our team? Explore career opportunities at https://jobs.lever.co/niagenbioscience +Based on the top selling dietary supplement brands by revenue per the largest U.S. e-commerce marketplace. (1/1/24-12/31/24)